Integral Diagnostics Ltd

IDX: XASX (AUS)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
LOCK|$ntWk&LOCK|VfLOCK|B<>&^G

Intention to Cease Coverage of Integral Diagnostics, Australian Clinical Labs, Healius, Nanosonics

We intend to cease coverage of Integral Diagnostics, Australian Clinical Labs, Healius and Nanosonics. We plan to cease coverage on or around June 30, 2026.

Sponsor Center